drugset / Trial / NCT00277472
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will assess the efficacy and safety of valsartan/hydrochlorothiazide combination therapy in patients with hypertension not controlled with hydrochlorothiazide monotherapy.
Timeline
- Start
- 2005-11
- Primary completion
- 2005-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydrochlorothiazide | Unknown | 12.5 mg | Oral |
| Comparator | Hydrochlorothiazide | Unknown | 25 mg | Oral |
| Subject | Valsartan | Small molecule | 160 mg | Oral |